The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials

D. G. Bostwick, H. B. Burke, T. M. Wheeler, L. W.K. Chung, R. Bookstein, T. G. Pretlow, R. B. Nagle, R. Montironi, M. M. Lieber, R. W. Veltri, W. E. Grizzle, D. J. Grignon

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint Dive into the research topics of 'The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds